The Association Between Cyba Gene C242t Variant and Risk of Metabolic Syndrome Publisher Pubmed



Pourgholi L^{1, 2} ; Pourgholi F³ ; Ziaee S¹ ; Goodarzynejad H⁴ ; Hosseindokht M¹ ; Boroumand M¹ ; Mandegary A^{2, 5} Show Affiliations
Source: European Journal of Clinical Investigation Published:2020

Abstract

Background: Both inflammation and oxidative stress may contribute to pathogenesis of metabolic syndrome (MetS). The C242T polymorphism (rs4673) in the CYBA gene, as the main components of NAD (P) H oxidase, causes inter-individual variability in the enzyme activity. We aimed to investigate the association between this polymorphism with MetS and its components. Methods: Two hundred nine patients with MetS and 232 controls were included in this study. MetS was defined based on NCEP ATP-III A criteria with some modifications. The C242T polymorphism within CYBA gene was determined by using PCR-based restriction fragment length polymorphism (PCR-RFLP) method. Results: After applying a multiple logistic regression model with adjusting for potential confounders of MetS including, age, sex, body mass index, hypertension, used medications, and diabetes mellitus, C242T polymorphism was found to be associated with the presence of MetS in men but not in the total population or in women. T allele as compared to C allele was associated with decreased odds of MetS in men (adjusted OR = 0.42, 95% CI = 0.24-0.74; P =.003), but not in women (adjusted OR = 1.03, 95% CI = 0.07-1.61; P =.890), or in the total population (adjusted OR = 0.72, 95% CI = 0.51-1.02; P =.063). Conclusion: This study shows that T allele of C242T polymorphism in CYBA gene is protective against MetS in Iranian men but not in women. Further cohort studies with larger sample size in subgroups of men and women are required to confirm such association in other racial or ethnic group. © 2020 Stichting European Society for Clinical Investigation Journal Foundation